DT
XBI icon

Diversified Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Diversified Trust’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$906K Buy
5,726
+4,001
+232% +$541K 0.01% 545
2026
Q1 		$220K Buy
1,725
+44
+3% +$5.49K ﹤0.01% 947
2025
Q4 		$205K Buy
+1,681
New +$193K ﹤0.01% 966

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Diversified Trust's XBI Position: Q2 2026 in Review

Diversified Trust increased its State Street SPDR S&P Biotech ETF (XBI) stake by 232% in Q2 2026, buying an estimated $541K and bringing the position to 5,726 shares worth $906K. The position accounts for 0.01% of the portfolio, ranked #545.

Diversified Trust first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 225 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Diversified Trust held 5,726 shares of State Street SPDR S&P Biotech ETF worth $906K as of Q2 2026.
  • Diversified Trust bought 4,001 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $541K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #545 holding.
  • Diversified Trust first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 225 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.